ClinicalTrials.gg
RecruitingNCT04530760ATOMICUpdated Dec 23, 2025

Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical Ventilation

An observational study in Critical Illness and Cirrhosis, Liver, sponsored by University Hospital, Lille. Recruiting at 2 sites in France. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2025-12-23.

Primary conditionLiver CirrhosisRegistry: Critical IllnessReclassifiedWhy we changed it
Registry
Critical Illness — the first condition term the registry derived for this study.
ClinicalTrials.gg
Liver Cirrhosis
Why
  1. Critical Illness is a broad heading, used only when no more specific condition is named.
  2. The study's listed conditions name Liver Cirrhosis.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University Hospital, Lille · Observational

How we know

From the registry’s dates

  • Started Oct 2021; still recruiting 5 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
226
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 95 studies in Liver Cirrhosis with a site in France — 22 open to participants now, 25 under way, 2 of them phase 3. Liver Cirrhosis · France.

Planned enrollment
22nd of 41
226 · median 227
Started
2021
with 4 others
Observational
41 of 95
14 open now
Primary completion
2026-12
later than 6 of 24 live
Registered
53rd of 95
by date

Among the 95 studies in Liver Cirrhosis with a site in France, this one is the 22nd largest by planned enrollment of the 41 observational ones that give a count, is one of 5 that started in 2021, is one of 41 observational ones, reaches primary completion later than 6 of the 24 other live ones, and was the 53rd registered.

Liver Cirrhosis

1,303 studies on the registry are indexed under Liver Cirrhosis; 341 are open to participants now.

Browse Liver Cirrhosis studies →

Open to participants now

22 of the 95 studies in Liver Cirrhosis with a site in France are open now. Recruiting first, the newest first:

16 more — sign in →

All 22 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 208 Liver Cirrhosis studies recruiting now, 101 (49%) set no upper age limit and 66 (32%) stop at 75 or younger; 12 take children under 18; 25 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 95 studies in Liver Cirrhosis with a site in France, or all of them as a file.
02

Study summary

The study aims to demonstrate the relationship between intra-abdominal hypertension (IAH) and abundant microaspirations in mechanically ventilated cirrhotic.

Read the detailed description

Intra-abdominal pressure monitoring will be performed using intra-vesical pressure every 8 hour in the first 2 days of mechanical ventilation.

Micro aspiration is defined by pepsin or amylase positivity in trachea suction. Two groups will be compared : one with IAH , one without IAH.

03

Conditions studied

  • Critical Illness
  • Cirrhosis, Liver

Browse trials for

04

In context

Liver Cirrhosis Reclassified

1,303 studies on the registry are indexed under Liver Cirrhosis; 341 are open to participants now.

This study's planned enrollment of 226 is above the median of 172 across 528 observational studies indexed under Liver Cirrhosis.

Browse Liver Cirrhosis studies →

Lead sponsor

University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.

Compared within Liver Cirrhosis, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Critical Illness. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

cirrhotic patients receiving invasive mechanical ventilation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients
  • Cirrhosis
  • intubation and mechanical ventilation

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • oliguric patients
  • impossibility to measure intravesical pressure
06

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
226 participants (estimated)
Patient registry
No

Groups and cohorts

  • intraabdominal hypertension group

    patients with intraabdominal hypertension defined as intravesical pressure more than 12 mmHg

  • control group

    patients with no intraabdominal hypertension

07

What researchers measure

Primary outcomes

  1. abundant microaspiration

    presence of pepsin or alpha amylase at significant level in at least 30% of tracheal aspirates

    Time frame: 48 hours after inclusion

Secondary outcomes

  1. Mortality

    number of death

    Time frame: from ICU admission until day 28

  2. Incidence of ventilator associated pneumonia (VAP)

    percentage of patients with VAP

    Time frame: from intubation until day 28 or extubation

  3. duration of mechanical ventilation

    number of days with mechanical ventilation

    Time frame: from intubation until day 28 or extubation

  4. incidence of patients requiring renal replacement therapy

    percentage of patients with renal replacement treatment

    Time frame: from ICU admission until Day 28 or ICu discharge, whichever came first

  5. incidence of cirrhosis related complications

    percentage of patients with cirrhosis related complications

    Time frame: from ICU admission until Day 28 or ICU discharge, whichever came first

08

Study locations

2 of 2 sites recruiting
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2021 (actual). Primary completion is estimated for Dec 2026, 62 months after the start.

Of 231 non-industry observational studies under Liver Cirrhosis, half reached primary completion within 47 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 71. This study's planned 62 months is above that.

Counting every sponsor, half of 247 studies reached it within 47 months; a quarter within 18 and three quarters within 71.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 27, 2020
First posted
Aug 28, 2020
StartActual
Oct 8, 2021
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Dec 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04530760
Responsible party
Sponsor
First posted
Aug 28, 2020
Start date
Oct 8, 2021
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Dec 23, 2025

Study contacts

Saad Nseir, MD,PhD
Contact
saadalla.nseir@chru-lille.fr
0320444495 ext. +33
Saad Nseir, MD,PhD
principal investigator · University Hospital, Lille

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion